Chemically Induced Platelet Lysis Causes Vasoconstriction by Release of Serotonin
- 30 April 1998
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 149 (2), 235-242
- https://doi.org/10.1006/taap.1998.8387
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Metabolism and Cytotoxicity of Menadione and Its Metabolite in Rat PlateletsToxicology and Applied Pharmacology, 1997
- Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. A role for additional 5-hydroxytryptamine receptor antagonism against coronary vasospasm?Circulation, 1994
- Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries.Circulation, 1993
- 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteriesCardiovascular Research, 1990
- Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.Circulation, 1987
- Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.Circulation, 1986
- Platelet-mediated vascular permeability in the rat: A predominant role for 5-hydroxytryptamineThrombosis Research, 1985
- Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserinThrombosis Research, 1982
- COMPARISON OF THE ACTIONS OF U‐46619, A PROSTAGLANDIN H2‐ANALOGUE, WITH THOSE OF PROSTAGLANDIN H2 AND THROMBOXANE A2 ON SOME ISOLATED SMOOTH MUSCLE PREPARATIONSBritish Journal of Pharmacology, 1981
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976